Risk of breast cancer in women treated with ovarian stimulation drugs for infertility: a systematic review and meta-analysis
A systematic review and meta-analysis of 20 studies assessing the use of clomiphene citrate, gonadotropins, and their combined use did not identify an increased risk of breast cancer.
Yusuf Beebeejaun, B.Sc., M.B.B.S., Abbeyrahmee Athithan, B.Sc., Timothy P. Copeland, M.P.P., Mohan S. Kamath, M.S., D.N.B, Ippokratis Sarris, D.M., Sesh K. Sunkara, M.D.
Abstract:
Objective
To evaluate the evidence addressing the association between the use of ovarian stimulation drugs and the risk of breast cancer.
Design
Systematic review and meta-analysis.
Setting
Not applicable.
Patient(s)
Women without any previous history of breast cancer undergoing ovarian stimulation.
Intervention(s)
Electronic databases were searched from 1990 until January 2020. All cohort studies reporting new incidences of breast cancer in infertile women using ovarian stimulating drugs were included. Treated (exposed) infertile women were compared with the unexposed general population with unexposed infertile women as controls.
Main Outcome Measure(s)
New diagnosis of breast cancer within an infertile and general population after exposure to ovarian stimulation drugs.
Result(s)
Overall, the quality of evidence was very low because of the serious risk of bias and indirectness (nonrandomized studies). There was no significant increase in the risk of breast cancer among women treated with any ovarian stimulation drug for infertility compared with that in unexposed controls from the general population and the infertile population (pooled odds ratio 1.03, 95% Confidence interval 0.86 to 1.23, 20 studies, I2= 88.41%, very low quality of evidence). Furthermore, no significant increase in the risk of breast cancer was found with the use of clomiphene citrate or gonadotropins, alone or in combination.
Conclusion(s)
The current study found that the use of clomiphene citrate and gonadotropins in infertile women was not associated with an increased risk of breast cancer.
Your Fertility and Sterility Dialog login information is not the same as your ASRM or EES credentials. Users must create a separate account to comment or interact on the Dialog.
Risk of breast cancer in women treated with ovarian stimulation drugs for infertility: a systematic review and meta-analysis
A systematic review and meta-analysis of 20 studies assessing the use of clomiphene citrate, gonadotropins, and their combined use did not identify an increased risk of breast cancer.
This is a representation of how your post may appear on social media. The actual post will vary between social networks
We and selected partners, use cookies or similar technologies as specified in the cookie policy and privacy policy.
You can consent to the use of such technologies by closing this notice.
Cookie Control
Customise your preferences for any tracking technology
The following allows you to customize your consent preferences for any tracking technology used
to help us achieve the features and activities described below. To learn more about how these trackers help us
and how they work, refer to the cookie policy. You may review and change your preferences at any time.
These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.
These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.
Please sign in or register for FREE
Your Fertility and Sterility Dialog login information is not the same as your ASRM or EES credentials. Users must create a separate account to comment or interact on the Dialog.